tiprankstipranks
SeaStar Medical Holding (ICU)
NASDAQ:ICU
US Market

SeaStar Medical Holding (ICU) Income Statement

367 Followers

SeaStar Medical Holding Income Statement

Last quarter (Q4 2023), SeaStar Medical Holding's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, SeaStar Medical Holding's net income was $-12.70M. See SeaStar Medical Holding’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ -100.00K---$ 0.00
Cost of Revenue
-----
Gross Profit
$ -100.00K----
Operating Expense
$ 13.58M$ 14.21M$ -11.61M$ 1.12M$ 5.24K
Operating Income
$ -13.58M$ -14.21M$ -11.61M$ -1.12M$ -5.24K
Net Non Operating Interest Income Expense
$ -791.00K$ -1.08M$ -630.00K$ 11.82K-
Other Income Expense
$ 13.44M$ 10.94M$ 10.77M$ -1.19M-
Pretax Income
$ -33.67M$ -26.23M$ -23.01M$ 75.32K$ -5.24K
Tax Provision
--$ 1.00K--
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -33.67M$ -26.23M$ -23.01M$ 75.32K$ -5.24K
Basic EPS
$ -1.00$ -1.21$ -2.80-$ >-0.01
Diluted EPS
$ -1.00$ -1.21$ -2.80$ 0.04$ >-0.01
Basic Average Shares
$ 140.76M$ 21.67M$ 8.21M$ 12.21M$ 13.04M
Diluted Average Shares
$ 140.76M$ 21.67M$ 8.21M-$ 13.04M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 13.58M$ 14.21M$ -11.61M$ 1.12M$ 5.24K
Net Income From Continuing And Discontinued Operation
$ -33.67M$ -26.23M$ -23.01M$ 75.32K$ -5.24K
Normalized Income
$ -31.22M$ -20.72M--$ -5.24K
Interest Expense
-----
EBIT
$ -28.24M$ -26.28M$ -22.38M$ 63.50K$ -5.24K
EBITDA
$ -20.98M$ -26.23M$ -22.14M$ 63.50K$ -5.24K
Currency in USD

SeaStar Medical Holding Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis